IMARC Group’s report titled “Peripheral Vascular Devices Market Report by Device Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloon Catheters, Peripheral Transluminal Angioplasty (PTA) Guidewires, Atherectomy Devices, Embolic Protection Devices, Inferior Vena Cava Filters, and Others), End User (Hospitals and Clinics, Ambulatory Care Centers, Specialty Clinics, and Others), and Region 2025-2033” The global peripheral vascular devices market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

Factors Affecting the Growth of the Peripheral Vascular Devices Industry:

● Rising Prevalence of Chronic Diseases

The global peripheral vascular devices market is experiencing significant growth, primarily driven by the escalating prevalence of chronic diseases such as diabetes, obesity, and hypertension. These conditions significantly increase the risk of peripheral artery disease (PAD), a condition where blood flow to the limbs is restricted. As the incidence of these chronic diseases continues to rise, particularly in aging populations, the demand for effective treatment options like peripheral vascular devices is expected to surge.

● Technological Advancements and Minimally Invasive Procedures

Technological advancements in peripheral vascular devices are playing a crucial role in market growth. The development of innovative stents, balloons, and catheters enables less invasive procedures with shorter recovery times and improved patient outcomes. These advancements are increasingly favored by both physicians and patients, driving the adoption of minimally invasive interventions over traditional open surgeries.

● Growing Geriatric Population and Expanding Healthcare Infrastructure

The rapidly aging global population is another key factor contributing to market expansion. Older individuals are more susceptible to vascular diseases, leading to a higher demand for diagnostic and therapeutic interventions. Furthermore, the expansion of healthcare infrastructure in developing economies, coupled with increased access to advanced medical technologies, is creating significant growth opportunities for the peripheral vascular devices market in these regions.

Request for a sample copy of this report: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample

Leading Companies Operating in the Global Peripheral Vascular Devices Industry:

Peripheral Vascular Devices Market Report Segmentation:

Breakup by Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others

The report provides a detailed overview and analysis of the market by device type. This includes peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, embolic protection devices, inferior vena cava filters, and others. According to the report, peripheral vascular stents represent the largest segment.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others

The report also provides a detailed overview and analysis of the market based on the end user. This includes hospitals and clinics, ambulatory care centers, specialty clinics, and others. According to the report, hospitals and clinics have the largest share in the market.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market, accounting for the largest peripheral vascular devices market share

Global Peripheral Vascular Devices Market Trends

The market is primarily driven by the increasing prevalence of venous diseases or chronic venous insufficiency (CVI) across the globe. In addition, the rising geriatric population, and the increasing occurrences of various ailments, such as peripheral artery disease (PAD) and blockages, are contributing to the market growth. Moreover, the escalating demand for minimally invasive surgeries (MIS) owing to quick recovery rates, minor scaring, shortened hospital stay, and fewer chances of post-surgery infections represents another major growth-inducing factor. Furthermore, the extensive adoption of atherectomy devices due to the increasing prevalence of obesity, atherosclerosis, and lifestyle-related disorders is propelling the market growth. Other factors, including the expanding healthcare industry, rising disposable incomes of consumers, and extensive research and development (R&D) activities conducted by key players, are creating a positive market outlook.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145